1. SGK1.1 limits brain damage after status epilepticus through M current-dependent and independent mechanisms.
- Author
-
Martin-Batista E, Maglio LE, Armas-Capote N, Hernández G, Alvarez de la Rosa D, and Giraldez T
- Subjects
- Animals, Calcium-Binding Proteins metabolism, Cell Survival, Excitatory Amino Acid Agonists toxicity, Glial Fibrillary Acidic Protein metabolism, Gliosis metabolism, Gliosis pathology, Kainic Acid toxicity, Mice, Mice, Transgenic, Microfilament Proteins metabolism, Neuroglia metabolism, Neurons pathology, Status Epilepticus chemically induced, Status Epilepticus pathology, Apoptosis genetics, Gliosis genetics, Immediate-Early Proteins genetics, Neurons metabolism, Protein Serine-Threonine Kinases genetics, Status Epilepticus metabolism
- Abstract
Epilepsy is a neurological condition associated to significant brain damage produced by status epilepticus (SE) including neurodegeneration, gliosis and ectopic neurogenesis. Reduction of these processes constitutes a useful strategy to improve recovery and ameliorate negative outcomes after an initial insult. SGK1.1, the neuronal isoform of the serum and glucocorticoids-regulated kinase 1 (SGK1), has been shown to increase M-current density in neurons, leading to reduced excitability and protection against seizures. For this study, we used 4-5 months old male transgenic C57BL/6 J and FVB/NJ mice expressing near physiological levels of a constitutively active form of the kinase controlled by its endogenous promoter. Here we show that SGK1.1 activation potently reduces levels of neuronal death (assessed using Fluoro-Jade C staining) and reactive glial activation (reported by GFAP and Iba-1 markers) in limbic regions and cortex, 72 h after SE induced by kainate, even in the context of high seizure activity. This neuroprotective effect is not exclusively through M-current activation but is also directly linked to decreased apoptosis levels assessed by TUNEL assays and quantification of Bim and Bcl-x
L by western blot of hippocampal protein extracts. Our results demonstrate that this newly described antiapoptotic role of SGK1.1 activation acts synergistically with the regulation of cellular excitability, resulting in a significant reduction of SE-induced brain damage in areas relevant to epileptogenesis., (Copyright © 2021. Published by Elsevier Inc.)- Published
- 2021
- Full Text
- View/download PDF